New categories launched with awards for Accelerating Innovation, Start-ups and being at the Heart of Pharma The 20th-anniversary edition of the CPHI Pharma Awards is now open for entries, with …

Novartis and Biogen both walked away from separate neurodegenerative deals with Sangamo Therapeutics, leaving the California-based genomic medicine company scrambling to assess its options. Novartis was the first to …

The company raises €12m in financing with a view to entering the European market. Vitestro – a company that has developed autonomous blood drawing technology …

Research data follow the phase 3 EMBARK trial and involves men with non-metastatic prostate cancer. Astellas has announced positive results from its phase 3 EMBARK …

Combination therapy treats patients with metastatic castration-resistant prostate cancer. AstraZeneca and MSD have announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted …

Landing page whets visitors’ appetite for the trade fair The Interpack, the leading trade fair for the packaging and pharmaceutical industry, will open its doors …

This strategic alliance will give a unique advantage to pharmaceutical & biotech customers – accelerating the go-to-market of their drug-device combination products by offering analytical …

The clinical trial also involves paclitaxel in the treatment of metastatic breast cancer. Immutep – a company that concentrates on developing novel LAG-3 immunotherapies for …

Candidate AP30663 is an inhibitor for the conversion of atrial fibrillation to a normal sinus rhythm. Acesion Pharma – a company focused on novel therapies …

Norfolk and Norwich University Hospitals have been using two Mostcare Up devices since 2019. The complex procedure, Cytoreductive Surgery (CRS), is being directed by a …